News
Neuronet launches social media campaign – Why we do what we do
13 Sep 2019
Neuronet’s communication team and the community of communication representatives from the Innovative Medicines Initiative projects on neurodegeneration are pleased to announce that we will celebrate the great people behind our projects.
We will participate in a campaign on social media about why we do what we do and the value of participating in research.
Each day, one of the researchers respectively participants from the Innovative Medicines Initiative will speak up. We’ll link to some of the great findings, interesting activities and tools, none of which would have been possible without public-private collaboration.
Follow our programme on Twitter so that you can keep up to date with the series and keep an eye on #WeAreNeuronet:
More News
The Neuronet Coordination and Support Action releases updated Decision Tool for engagement with Regulatory and Health Technology Assessment bodies
09 May 2022
Madrid, 9 May 2022 – Today, the members of the
Big Data 4 Better Outcomes: Recommendations for the European Health Data Space
16 Jul 2021
In light of our experience in various projects of the Innovative Medicines Initiative’s Big Data 4...
